William K. Heiden
Director, rEVO Biologics, Inc.
Companies
- MACROGENICS INCBoard member May 24, 2022 to now1
- Atara Biotherapeutics, Inc.Board member Nov 25, 2015 to now2
- AMAG PharmaceuticalsBoard member May 16, 2012 to Mar 4, 20203
- AMAG PharmaceuticalsChief executive officer May 16, 2012 to Mar 4, 20203
- AMAG PharmaceuticalsPresident May 16, 2012 to Mar 4, 20203
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- MACROGENICS INC MGNX114,750 shares4$382.7K at $3.33May 18, 2026
- Atara Biotherapeutics, Inc. ATRA34,188 shares5$315.9K at $9.24Jun 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 9, 2026Granted 12,000 shares of Atara Biotherapeutics, Inc.5
- May 18, 2026Exercised options 3,750 shares of MACROGENICS INC4
- Aug 20, 2025Bought 49,500 shares at $1.49 of MACROGENICS INC6
- Aug 19, 2025Bought 50,500 shares at $1.52 of MACROGENICS INC6
- Jun 10, 2025Granted 7,828 shares of Atara Biotherapeutics, Inc.7
- May 20, 2025Exercised options 6,500 shares of MACROGENICS INC8
- May 20, 2024Exercised options 4,500 shares of MACROGENICS INC9
- Mar 31, 2024Granted 150,000 shares of Atara Biotherapeutics, Inc.10
- Nov 10, 2023Bought 100,000 shares at $0.25 of Atara Biotherapeutics, Inc.11
- May 31, 2023Granted 57,000 shares of Atara Biotherapeutics, Inc.12
- Jun 23, 2022Granted 20,500 shares of Atara Biotherapeutics, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMACROGENICS INC, Board member
- 2
- 3SEC EDGARAMAG Pharmaceuticals, Board member
- 4
- 5
- 6SEC EDGARForm 4 filed Aug 21, 2025
- 7SEC EDGARForm 4 filed Jun 12, 2025
- 8SEC EDGARForm 4 filed May 22, 2025
- 9SEC EDGARForm 4 filed May 22, 2024
- 10SEC EDGARForm 4 filed Apr 2, 2024
- 11SEC EDGARForm 4 filed Nov 14, 2023
- 12SEC EDGARForm 4 filed Jun 2, 2023
- 13SEC EDGARForm 4 filed Jun 27, 2022